Early Threat Detection
Detect low-amplitude signals for early identification of emerging viral threats.
ViRx@Stanford AI to Counter Pandemics Industry Affiliates Program
The innovation of academia. The rigor of industry.
The ViRx@Stanford AI to Counter Pandemics Industry Affiliates Program (ViRx-AI) brings member companies together with our faculty in a pre-competitive research environment. Our goal is to deliver real-world drugs.
Focus Areas
Using AI to counter pandemics
Affiliates engage directly with the AI research driving our antiviral pipeline — from first signal to clinical candidate.
Rapid Candidate Discovery
Rapidly identify and develop drug candidates with high selectivity for identified viral threats.
Clinical-Grade Optimization
Multi-parameter optimization of antiviral candidates for clinical development, leveraging reinforcement learning.
Our Platforms
Combined with proven antiviral platforms
AI-REALSMART-V Platform
Targets highly conserved amphipathic helix structures in viral genomes and leverages our proprietary focused medicinal chemistry library — recipient of the BARDA antiviral prize.
Programmable Antivirals Platform
Targets highly conserved essential RNA secondary structures in viral genomes.
Host-Targeting Antivirals
Pioneering host-targeting, well-tolerated, multi-purpose antivirals.
Clinical Translation & New Companies
Unique expertise and experience in designing and bringing antivirals to the clinic, and in the formation of new companies.
Program Faculty
Faculty leading the program
Jeffrey Glenn, M.D., Ph.D.
Director, ViRx@Stanford
Edward Pham, M.D., Ph.D.
Deputy Director for Translational Research
Wah Chiu, Ph.D.
Program Faculty, Stanford University
Catherine Blish, M.D., Ph.D.
Program Faculty, Stanford University
Ron Dror, Ph.D.
Program Faculty, Stanford University
Membership
Two ways to join the program
Full Membership
$5M / year
Minimum three-year commitment
- Dedicated ViRx@Stanford research updates
- Named sponsor of all ViRx@Stanford symposia
- Complimentary access to Stanford ViRx@Stanford symposia
- Complimentary access to global ViRx@Stanford symposia
- Opportunity to participate in the Visiting Scholar Program
- Engagement with Program faculty and students
- Opportunities to recruit students
Exploratory Membership
Contact us
For organizations exploring engagement with the program
- Complimentary access to Stanford ViRx@Stanford symposia
Membership benefits do not include a statement of work, deliverables, or any rights or licenses to intellectual property. More directed research relationships may be arranged through sponsored research agreements, in accordance with Stanford's policy for Industrial Affiliate Programs (RPH 13.4).
Become an Affiliate
Join the companies building the world's antiviral defense system
Let's talk about what ViRx-AI membership can make possible for your organization.